Search Results

Nicola leads Business Development for AES, building and developing the AES commercial team. In this role since 2022, her strategic focus and operational knowledge of study start up and patient…

Over the past several years, there have been many changes in the pharmaceutical industry, as our clients strive to maximize the return on their research & development investments. One area…

The French Sunshine Act (FSA) aims to strengthen transparency in the various interactions between health care providers (HCPs) and life sciences companies with the objective of preventing possible conflicts of…

Let us help you find the right patients for the right trial at the right time As the industry’s high-performance trial delivery company, AES combines exceptional patient access and a consolidated…

Let us help you get your clinical trial enrollment back on track As the industry’s high-performance trial delivery company, AES combines exceptional patient access and a consolidated global infrastructure of highly…

…discover how AES uses our global clinical trial research sites and trial enrollment solutions to quickly and effectively recruit to deliver the large numbers of volunteers needed for vaccine studies….

…risk. And working in a pay-for-performance model demonstrates our strong commitment to delivering the patients you need. Contact us Get in touch to discuss performance-based pricing for your clinical trial…

…patients choose to engage Messaging that understands Messaging that understands patient needs and motivations Continuous analysis Continuous analysis to optimize campaign performance Support Support from physician referrals and local community…

…including Mosaic, global billing and numerous other initiatives. Previously, Richard established and led the strategic finance team and served as business partner to the chief commercial officer for five years….